Nausea Relief Chews Market Share, Size, Trends, Industry Analysis Report, By Indication (Poultry, Cattle, Swine, Horse, and Others); By Distribution Channel; By Distribution Channel; By Region; Segment Forecast, 2023 – 2032

Nausea Relief Chews Market Share, Size, Trends, Industry Analysis Report, By Indication (Poultry, Cattle, Swine, Horse, and Others); By Distribution Channel; By Distribution Channel; By Region; Segment Forecast, 2023 – 2032

The global nausea relief chews market size is expected to reach USD 841.40 million by 2032, according to a new study by Polaris Market Research. The report “Nausea Relief Chews Market Share, Size, Trends, Industry Analysis Report, By Indication (Gastroesophageal Reflux Disease, and Motion Sickness and Seasickness); By Distribution Channel; By Region; Segment Forecast, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The increasing number of individuals preferring non-pharmaceutical solutions for nausea and vomiting over prescription medications due to growing concerns about side effects and dependency and rising consumer disposable income leading to higher spending on health & wellness products, including nausea chews, are prominent factors fostering the global market growth.

Besides this, a large number of government agencies are introducing favorable regulatory environments and approving over-the-counter medications and supplements for the treatment of several disease symptoms, including nausea and vomiting, and are collaborating with healthcare providers and hospitals to expand the product market in various emerging or untapped markets.

For instance, in January 2022, AbbVie announced that the U.S. Food and Drug Administration approved the RINVOQ for the treatment of dermatitis in both adults and children aged 12 years or older. The side effects of RINVOQ include nausea, cough, fever, acne, headache, cold sores, and various upper respiratory tract infections, among others.

With the constant surge in the trend towards using natural and herbal ingredients in various types of healthcare products, including nausea relief chews, leading market companies are investing in research and development efforts on identifying and utilizing the botanical extracts and herbal compounds known for their anti-nausea properties, to cater to the growing demand for natural ingredients based-chews globally.

The drastic growth in the global travel & tourism industry and the increasing number of people flying long-haul flights for both business & leisure purposes creating a lucrative and immersing opportunity for nausea chews as an effective remedy for motion sickness and are likely to bode well for market growth in the near future.

For instance, according to our findings, the foreign tourist arrivals in India totaled 3.13 million people in the first four months of 2023, with a robust growth from 1.17 million arrivals in the same period of 2022. And over 8.47 million people in the country traveled out of the country in the period compared to 5.32 million a year ago.

Nausea Relief Chews Market Report Highlights

Motion sickness and sea-sickness segment accounted for notable market share, mainly due to the growing prevalence of motion sickness because of rising travel activities.

The online sales segment will grow at the highest pace, mainly accelerated by the rising emergence of healthcare e-commerce stores and the shift towards online platforms.

North America dominated the global with a considerable share, mainly due to the region’s well-developed healthcare infrastructure and higher spending on herbal remedies.

The key market players include Prestige Consumer Healthcare, Cipla, Emetrol Chewables, Ginger People, Mighty Petz, and Pepto Bismol.

Polaris Market Research has segmented the nausea relief chews market report based on indication, distribution channel. and region:

Nausea Relief Chews, Indication Outlook (Revenue - USD Billion, 2023 - 2032)

Gastroesophageal Reflux Disease

Motion Sickness and Seasickness

Nausea Relief Chews, Distribution Channel Outlook (Revenue - USD Billion, 2023 - 2032)

Online Sales

Supermarkets & Hypermarkets

Hospital Pharmacies

Others

Nausea Relief Chews, Regional Outlook (Revenue - USD Billion, 2023 - 2032)

North America

U.S.

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa